VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization GlobeNewswire January 08, 2026 VarmX and Rentschler Biopharma expand collaboration from early development to lateâ€'stage and commercial manufacturing of VMX-C001 VMXâ€'C001 builds on strong regulatory momentum, including FDA Fast Track Designation and PMDA Phase 1 waiver, as it progresses toward […]

Xali Gold Commences Work on Pico Machay Gold Project in Peru GlobeNewswire January 08, 2026 VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) — Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) is pleased to announce that work has commenced on the recently acquired Pico Machay Gold Project (“Pico Machay” or the “Project”). Xali

Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria GlobeNewswire January 08, 2026 67% of additional patients (n=6) enrolled in the BEACON study achieved a complete response at 12 weeks with a mean UAS7 reduction of 31 points 75% of CSU participants (n=36) enrolled in the open label extension study achieved

Brunswick Exploration Announces Inferred Mineral Resource of 52.2Mt at 1.08% Li2O at Mirage with Additional Exploration Target GlobeNewswire January 08, 2026 MONTREAL, Jan. 08, 2026 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Company“) is very pleased to announce a maiden, open-pit Mineral Inferred Resource Estimate (“MRE“) of 52.2 million

Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill(R) for the Treatment of Obesity in Collaboration with ProGen GlobeNewswire January 08, 2026 – A phase 1 study to evaluate safety, tolerability, bioavailability, pharmacokinetics, and weight loss of GLP-1/GLP-2 dual agonist, PG-102, administered orally via RaniPill(R) capsule versus subcutaneous injection – SAN JOSE, Calif., Jan. 08,

Surge Copper Advances Berg Toward Pre-Feasibility with Successful 2025 Drilling and Data Validation Program GlobeNewswire January 08, 2026 Vancouver, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) — Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to report results from its 2025 multidisciplinary drilling and field program at the

Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts GlobeNewswire January 08, 2026 – Multi-asset pipeline with significant targeted data readouts and milestones – – Two lead ophthalmic gene therapy programs in clinical trials with new data anticipated in 2026 – – Supplemental New Drug Application (sNDA) submitted for partnered presbyopia treatment – – Corporate

Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities U.S. IPE Market Leadership Sustained; $70M Restructuring OPEX Savings on Pace for Mid-2026; Completed Transition to Fully Partnered Model Across All International Markets GlobeNewswire January 08, 2026 DUBLIN and BRIDGEWATER, N.J., Jan. 08,

Woof Gang Achieves Record Growth in 2025 America's largest pet grooming brand reports 25% YoY sales increase; doubles its footprint in three years GlobeNewswire January 08, 2026 MIAMI, Jan. 08, 2026 (GLOBE NEWSWIRE) — Woof Gang Bakery & Grooming (“Woof Gang” or “the Company”), the neighborhood pet grooming and treat boutique, today announced record-breaking results

Anika Therapeutics Announces Leadership Transition GlobeNewswire January 08, 2026 Stephen (Steve) Griffin, Current Chief Financial Officer and Chief Operating Officer, Appointed President and Chief Executive Officer Cheryl Blanchard to Become Executive Chair of the Board of Directors BEDFORD, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the